On August 29, RELX YUEKE (Wuxin Technology) launched its new national standard product for sale on a unified e-cigarette trading platform across the country. YUEKE announced in a statement that this is another important milestone for the company to embrace the industry's standard development in a new era. Currently, YUEKE has multiple products that have passed the technical review, and more are still undergoing technical review. According to media reports, on the same morning, a certain e-cigarette store in Futian District, Shenzhen sold the first national standard e-cigarette product from YUEKE across the country.
The release of the national standard for electronic cigarettes has placed higher requirements on the quality and safety of these products. It is reported that in order to pursue the ultimate vaping experience, Yooz has fully upgraded its research and development system during the development of products that conform to the national standard.
Yueke, a company specializing in electronic cigarettes, has expanded its laboratory matrix by adding three new labs: the Aerosol Innovation Lab, the Aerosol Lab, and the New Material Lab. These new labs join the existing matrix, resulting in a total of eight labs and strict factory quality control. This expansion signifies improvement in Yueke's product quality, flavor development, user experience, and scientific exploration, all of which are integral parts of the company's comprehensive technological approach.
Since the laboratory's first operation in 2019, YUEKE has invested a total of 800 million yuan in research and development, culminating in the formation of a "1+4" scientific research path in 2020 and a comprehensive upgrade of its development system. The significance of YUEKE products goes beyond companionship and emphasizes trust. The company promises to adhere to regulatory requirements and maintain product quality while constantly iterating its core technology platform in pursuit of a perfect experience and offering users pure and delicious products. YUEKE Founder and CEO Wang Ying stated this.
How are national standard products developed? Take a tour of the 8 major laboratories at Yueke.
The upgraded Yueke Laboratory Matrix now has a total area of approximately 6000 square meters, equivalent to about 14 standard basketball courts, which is five times larger than before. Upon entering, one can see various professional instruments running smoothly under the control of laboratory personnel. It has been reported that Yueke invested over 50 million yuan in this upgrade.
The 8 major laboratory matrix includes the innovation laboratory, chemical laboratory, life science laboratory, atomization innovation laboratory, new material laboratory, aerosol laboratory, quality safety laboratory, and sensory analysis laboratory. In addition, an after-sales quality testing center is also established. This matrix fully covers the user experience process and rigorously observes every checkpoint of the product experience.
The Innovation Laboratory is the first stage of creation for Yoozoo products. During our visit, engineers were carefully developing products that adhere to national standards. When asked about the laboratory's connection to product design, one engineer explained, "We start by identifying user pain points. For example, our new 3D scanner allows us to observe product structures with micron accuracy, improving product coupling and ensuring the optimal distance between the pod and cigarette holder.
The flavor and safety of the e-liquids that are most concerning to consumers are ensured by the joint efforts of four laboratories: the chemical laboratory, the aerosol laboratory, the innovative aerosol laboratory, and the sensory analysis laboratory.
In terms of safety, Yueke has continuously improved its testing standards over the years. The chemical laboratory is capable of conducting various aerosol liquid testing projects that comply with national standards, thereby preventing improper additions. "The newly established aerosol and new material laboratories provide us with a more fundamental research capability, enabling us to analyze key elements in greater depth to further enhance product safety and user experience," said Jiang Xingtao, head of Yueke's scientific center.
It is noteworthy that there is a new aerosol innovation laboratory. Through technological innovation such as raw material purification and flavor perception, the laboratory has greatly reduced the risk of product pastiness and odor variation. They have mastered the core technology of "low nicotine content and high satisfaction," which can further reduce the risk of nicotine addiction while ensuring a pure taste.
The visit here is not yet over: once it is confirmed for mass production, the product will need to undergo a series of reliability tests in the quality and safety laboratory. For instance, engineers will monitor the decibel level of the sound produced when the product is in use in a soundproof box, to ensure a top-notch user experience in terms of usage details. It is reported that the upgraded quality and safety laboratory is capable of conducting product testing in accordance with national standards, and it obtained accreditation from the China National Accreditation Service for Conformity Assessment (CNAS) in August 2022.
Behind the launch of national standard products: Yueke continues to advance into the uncharted territory of atomization science.
Why upgrade the laboratory matrix? According to Yooztec co-founder and head of research and supply chain, Wen Yilong, the answer is "standardized development." "As electronic cigarettes enter a new era of standardized development, technological innovation becomes more important," he said. "Only by prioritizing quality and safety, enhancing technological innovation and R&D, can we provide users with better compliance products.
In recent years, YUEKE has made steadfast investments in innovative research and development, achieving a strong intellectual property layout and building a protective moat. According to a public patent database, as of June 2022, YUEKE has applied for over 610 patents worldwide, covering various aspects such as electronic atomizer design, atomization liquid formula, electronic control, intelligence, and release safety. Several of these patents have significant breakthroughs within the industry.
With the upgrade of the laboratory matrix, YUEKE's cutting-edge scientific exploration has taken a step forward. In September 2020, YUEKE launched its life science laboratory, establishing a scientific research path for the first time. While ensuring product quality, the laboratory has set up four major modules: physical and chemical research, toxicological research, clinical research, and long-term impact assessment, striving to fill the gap in domestic nebulization scientific research.
On the road to advancing science, Yoozoo has achieved several "industry-firsts" and even "firsts in China" in research. In March 2021, Yoozoo launched China's first clinical study of electronic cigarettes, which was approved by the China Clinical Trial Registration Center (ChiCTR) and the World Health Organization International Clinical Trial Registration Platform (WHO ICTRP). In February 2022, its first clinical research project focusing on "e-cigarette safety" in China was also successfully registered with the China Clinical Trial Registration Center. Yoozoo's scientific team has also published e-cigarette-related research papers in several SCI journals, such as Applied Toxicology, Ecotoxicology and Environmental Safety.
Currently, YUEKE has launched a series of collaborations with 10 universities, including Sun Yat-sen University and the Advanced Institute of Shenzhen, Chinese Academy of Sciences, 2 hospitals, and numerous scientific research and commissioned research institutions. In 2021, a total of 13 different dimension external cooperation projects were carried out.
“To become a trustworthy company, YUEKE has a responsibility to continue advancing in the field of atomization technology,” said Wen Yilong. “We believe that only by not avoiding or giving up on difficult problems can we turn fundamental research results into the power of product innovation, injecting unlimited possibilities into the industry's future.”
This article contains content that has been reprinted from a third-party source. The copyrights belong to the original media and author. If there is any infringement, please contact us to have it removed. Any individuals or organizations that wish to reprint this content must contact the author directly and not repost it without permission.
Disclaimer
This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.
Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.
The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.
This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.
Copyright Notice
This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.
No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.
For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.
AI-Assisted Translation and Editing Notice
Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.
Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.
